| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |